Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CHMP Recommends Three Approvals And Two Label Expansions, Makes One Denial

27 Jun 2008

EMEA recommends against use of epoetins in some cancer patients.

Related Content

UCB’s Vimpat NDA Seeks Indications For Epileptic Seizures, Diabetic Pain

29 Nov 2007

Actelion Vows To Keep PAH Lead, Despite First-Quarter Dip

22 Apr 2008

Amgen’s Anemia Drugs Weaken In First Quarter

24 Apr 2008

Lilly Wins Fibromyalgia Management Indication For Cymbalta

16 Jun 2008

J&amp;J’s Intelence Approved For HIV Treatment In NNRTI-Resistant Patients

22 Jan 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.